Literature DB >> 17414212

Protease-activated receptor signaling: new roles and regulatory mechanisms.

Stephen F Traynelis1, Joann Trejo.   

Abstract

PURPOSE OF REVIEW: Protease-activated receptors are G-protein-coupled receptors that transmit cellular responses to coagulant proteases in a variety of cell types in the vasculature and other tissues. Several other proteases can activate protease-activated receptors in vitro and may affect their function in vivo. While a role for these receptors in hemostasis and thrombosis has been established, their functions in inflammatory and other responses have yet to be fully elucidated. In addition, the mechanisms responsible for protease and cell type-specific signaling mediated by these receptors are largely undefined. Here, we highlight recent advances in understanding the roles and regulation of protease-activated receptor signaling. RECENT
FINDINGS: Recent studies have increased our knowledge of the function of protease-activated receptor signaling in platelets and its contribution to thrombosis. In other cell types, recent work has revealed new connections between these receptors and signaling effectors important for vascular development and inflammatory responses. Other studies have advanced our understanding of protease and cell type-specific responses as well as novel regulatory mechanisms for control of protease-activated receptor signaling.
SUMMARY: Thus, elucidating the signaling and regulatory mechanisms of protease-activated receptors in various tissues and cell types is important for understanding their biological function as well as for designing therapeutic strategies to control their function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17414212     DOI: 10.1097/MOH.0b013e3280dce568

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  49 in total

1.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

2.  Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.

Authors:  Kelly L McCoy; Stefka Gyoneva; Christopher P Vellano; Alan V Smrcka; Stephen F Traynelis; John R Hepler
Journal:  Cell Signal       Date:  2012-01-28       Impact factor: 4.315

3.  Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.

Authors:  Gabriel J Villares; Maya Zigler; Andrey S Dobroff; Hua Wang; Renduo Song; Vladislava O Melnikova; Li Huang; Russell R Braeuer; Menashe Bar-Eli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

4.  Mutation-prone points in thrombin receptor.

Authors:  Viroj Wiwanitkit
Journal:  J Thromb Thrombolysis       Date:  2007-12-07       Impact factor: 2.300

Review 5.  Proteases display biased agonism at protease-activated receptors: location matters!

Authors:  Angela Russo; Unice J K Soh; JoAnn Trejo
Journal:  Mol Interv       Date:  2009-04

6.  Protease-activated receptors modulate excitability of murine colonic smooth muscles by differential effects on interstitial cells.

Authors:  Tae Sik Sung; Heung Up Kim; Jeong Hwan Kim; Hongli Lu; Kenton M Sanders; Sang Don Koh
Journal:  J Physiol       Date:  2015-02-04       Impact factor: 5.182

7.  Thrombin: is it on a par with seizures and epilepsy?

Authors:  Kevin M Kelly
Journal:  Epilepsy Curr       Date:  2008 Jul-Aug       Impact factor: 7.500

8.  The N terminus of the adhesion G protein-coupled receptor GPR56 controls receptor signaling activity.

Authors:  Kevin J Paavola; Jason R Stephenson; Stefanie L Ritter; Shawn P Alter; Randy A Hall
Journal:  J Biol Chem       Date:  2011-06-27       Impact factor: 5.157

9.  Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.

Authors:  Daruoosh Zare; Mohammad Amin Rajizadeh; Marzieh Maneshian; Hossein Jonaidi; Vahid Sheibani; Majid Asadi-Shekaari; Manouchehr Yousefi; Khadijeh Esmaeilpour
Journal:  Psychopharmacology (Berl)       Date:  2021-02-23       Impact factor: 4.530

10.  PAR-2 triggers placenta-derived protease-induced altered VE-cadherin reorganization at endothelial junctions in preeclampsia.

Authors:  Y Gu; L J Groome; J S Alexander; Y Wang
Journal:  Placenta       Date:  2012-07-26       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.